Article
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Season 2, Episode 18: Turning the Page with Chadi Nabhan
Join Michael Pietrack on the Pharmaverse Podcast as he sits down with Dr. Chadi Nabhan, MD – CMO and Head of Strategy at RyghtAI, hematologist, oncologist, author, and podcast host – to explore the future of clinical trials, AI innovation, and leadership in healthcare.
In this episode, Dr. Nabhan shares:
✔️How RyghtAI uses AI digital twins to speed up clinical trials and reduce costs.
✔️The process of matching clinical trial protocols to the best sites worldwide.
✔️Lessons learned from mentorship, leadership, and his medical career.
✔️Insights from his books, including Toxic Exposure and The Cancer Journey.
✔️Strategies for balancing executive roles, healthcare innovation, and family life.
Whether you’re interested in AI in healthcare, clinical research, or leadership in biotech, this conversation is full of practical advice and inspiring stories.
Related Topics
You May Also Like
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Thakur, Sayanta & Lahiry, Sandeep
Accelerated drug approvals in oncology: Pros and cons
Article
Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
Article
Laleh Amiri-Kordestani & Richard Pazdur
Oncology approvals in 2020: a year of firsts in the midst of a pandemic
Article
Sean X Zhang, MSc , Dean Fergusson, PhD , Jonathan Kimmelman, PhD